Ribera, J., Granada, I., Morgades, M., González, T., Ciudad, J., Such, E., . . . (SEHH), P. E. d. T. e. H. (. G. S. S. O. H. (2021). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/ TCF3‐PBX1 treated with measurable residual disease‐oriented protocols.
Citación estilo ChicagoRibera, Jordi, et al. Prognostic Heterogeneity of Adult B‐cell Precursor Acute Lymphoblastic Leukaemia Patients With T(1;19)(q23;p13)/ TCF3‐PBX1 Treated With Measurable Residual Disease‐oriented Protocols. 2021.
Cita MLARibera, Jordi, et al. Prognostic Heterogeneity of Adult B‐cell Precursor Acute Lymphoblastic Leukaemia Patients With T(1;19)(q23;p13)/ TCF3‐PBX1 Treated With Measurable Residual Disease‐oriented Protocols. 2021.